Protein kinase, kinase A regulatory subunit Uncharacterized
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | yes | yes: 4 | 
| Forrest at al. (procyclic) | yes | yes: 4 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | yes | yes: 15 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | yes | yes: 12 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 12 | 
| NetGPI | no | yes: 0, no: 12 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005929 | cilium | 4 | 13 | 
| GO:0042995 | cell projection | 2 | 13 | 
| GO:0043226 | organelle | 2 | 13 | 
| GO:0043227 | membrane-bounded organelle | 3 | 13 | 
| GO:0110165 | cellular anatomical entity | 1 | 13 | 
| GO:0120025 | plasma membrane bounded cell projection | 3 | 13 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pescher et al. (upgregulation) | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| 
                        
                            Lahav et al. - mRNA 
                            - Protein 
                        
                     | 
                    
Related structures:
AlphaFold database: A4HVF2
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003341 | cilium movement | 4 | 1 | 
| GO:0007017 | microtubule-based process | 2 | 1 | 
| GO:0007018 | microtubule-based movement | 3 | 1 | 
| GO:0009987 | cellular process | 1 | 5 | 
| GO:0044145 | modulation of formation of structure involved in a symbiotic process | 3 | 1 | 
| GO:0050789 | regulation of biological process | 2 | 1 | 
| GO:0060294 | cilium movement involved in cell motility | 5 | 1 | 
| GO:0065007 | biological regulation | 1 | 1 | 
| GO:0006793 | phosphorus metabolic process | 3 | 4 | 
| GO:0006796 | phosphate-containing compound metabolic process | 4 | 4 | 
| GO:0008152 | metabolic process | 1 | 4 | 
| GO:0016310 | phosphorylation | 5 | 4 | 
| GO:0044237 | cellular metabolic process | 2 | 4 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 4 | 
| GO:0016301 | kinase activity | 4 | 4 | 
| GO:0016740 | transferase activity | 2 | 4 | 
| GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 4 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 122 | 124 | PF00675 | 0.397 | 
| CLV_NRD_NRD_1 | 133 | 135 | PF00675 | 0.375 | 
| CLV_NRD_NRD_1 | 203 | 205 | PF00675 | 0.573 | 
| CLV_NRD_NRD_1 | 351 | 353 | PF00675 | 0.404 | 
| CLV_NRD_NRD_1 | 460 | 462 | PF00675 | 0.324 | 
| CLV_PCSK_FUR_1 | 201 | 205 | PF00082 | 0.637 | 
| CLV_PCSK_KEX2_1 | 133 | 135 | PF00082 | 0.372 | 
| CLV_PCSK_KEX2_1 | 203 | 205 | PF00082 | 0.570 | 
| CLV_PCSK_KEX2_1 | 350 | 352 | PF00082 | 0.401 | 
| CLV_PCSK_KEX2_1 | 460 | 462 | PF00082 | 0.324 | 
| CLV_PCSK_KEX2_1 | 475 | 477 | PF00082 | 0.478 | 
| CLV_PCSK_PC1ET2_1 | 475 | 477 | PF00082 | 0.455 | 
| CLV_PCSK_SKI1_1 | 123 | 127 | PF00082 | 0.384 | 
| CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.481 | 
| CLV_PCSK_SKI1_1 | 251 | 255 | PF00082 | 0.473 | 
| CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.341 | 
| DEG_APCC_DBOX_1 | 133 | 141 | PF00400 | 0.530 | 
| DEG_APCC_DBOX_1 | 52 | 60 | PF00400 | 0.350 | 
| DOC_CDC14_PxL_1 | 359 | 367 | PF14671 | 0.420 | 
| DOC_CKS1_1 | 20 | 25 | PF01111 | 0.544 | 
| DOC_CKS1_1 | 315 | 320 | PF01111 | 0.324 | 
| DOC_CYCLIN_RxL_1 | 120 | 127 | PF00134 | 0.408 | 
| DOC_MAPK_gen_1 | 133 | 140 | PF00069 | 0.362 | 
| DOC_MAPK_gen_1 | 201 | 209 | PF00069 | 0.668 | 
| DOC_PP1_RVXF_1 | 142 | 148 | PF00149 | 0.404 | 
| DOC_PP1_RVXF_1 | 24 | 31 | PF00149 | 0.550 | 
| DOC_USP7_MATH_1 | 379 | 383 | PF00917 | 0.419 | 
| DOC_USP7_UBL2_3 | 294 | 298 | PF12436 | 0.337 | 
| DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.373 | 
| DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.540 | 
| DOC_WW_Pin1_4 | 314 | 319 | PF00397 | 0.324 | 
| LIG_14-3-3_CanoR_1 | 123 | 129 | PF00244 | 0.495 | 
| LIG_14-3-3_CanoR_1 | 203 | 208 | PF00244 | 0.563 | 
| LIG_14-3-3_CanoR_1 | 476 | 486 | PF00244 | 0.468 | 
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.531 | 
| LIG_BIR_III_4 | 415 | 419 | PF00653 | 0.389 | 
| LIG_BRCT_BRCA1_1 | 381 | 385 | PF00533 | 0.412 | 
| LIG_eIF4E_1 | 120 | 126 | PF01652 | 0.388 | 
| LIG_FHA_1 | 189 | 195 | PF00498 | 0.706 | 
| LIG_FHA_1 | 204 | 210 | PF00498 | 0.587 | 
| LIG_FHA_1 | 230 | 236 | PF00498 | 0.447 | 
| LIG_FHA_1 | 315 | 321 | PF00498 | 0.324 | 
| LIG_FHA_1 | 325 | 331 | PF00498 | 0.324 | 
| LIG_FHA_1 | 406 | 412 | PF00498 | 0.345 | 
| LIG_FHA_1 | 453 | 459 | PF00498 | 0.346 | 
| LIG_FHA_2 | 141 | 147 | PF00498 | 0.414 | 
| LIG_FHA_2 | 275 | 281 | PF00498 | 0.389 | 
| LIG_FHA_2 | 379 | 385 | PF00498 | 0.482 | 
| LIG_FHA_2 | 441 | 447 | PF00498 | 0.412 | 
| LIG_LIR_Apic_2 | 312 | 318 | PF02991 | 0.324 | 
| LIG_LIR_Gen_1 | 35 | 45 | PF02991 | 0.517 | 
| LIG_LIR_Gen_1 | 353 | 363 | PF02991 | 0.405 | 
| LIG_LIR_Gen_1 | 369 | 379 | PF02991 | 0.343 | 
| LIG_LIR_Gen_1 | 397 | 405 | PF02991 | 0.324 | 
| LIG_LIR_Gen_1 | 484 | 490 | PF02991 | 0.470 | 
| LIG_LIR_Nem_3 | 338 | 343 | PF02991 | 0.319 | 
| LIG_LIR_Nem_3 | 35 | 40 | PF02991 | 0.524 | 
| LIG_LIR_Nem_3 | 397 | 403 | PF02991 | 0.312 | 
| LIG_LIR_Nem_3 | 480 | 486 | PF02991 | 0.452 | 
| LIG_LIR_Nem_3 | 66 | 71 | PF02991 | 0.415 | 
| LIG_PCNA_yPIPBox_3 | 21 | 31 | PF02747 | 0.452 | 
| LIG_PTB_Apo_2 | 77 | 84 | PF02174 | 0.523 | 
| LIG_Rb_pABgroove_1 | 309 | 317 | PF01858 | 0.340 | 
| LIG_SH2_CRK | 315 | 319 | PF00017 | 0.311 | 
| LIG_SH2_CRK | 340 | 344 | PF00017 | 0.340 | 
| LIG_SH2_CRK | 486 | 490 | PF00017 | 0.450 | 
| LIG_SH2_NCK_1 | 315 | 319 | PF00017 | 0.406 | 
| LIG_SH2_PTP2 | 220 | 223 | PF00017 | 0.545 | 
| LIG_SH2_PTP2 | 402 | 405 | PF00017 | 0.399 | 
| LIG_SH2_SRC | 220 | 223 | PF00017 | 0.567 | 
| LIG_SH2_SRC | 390 | 393 | PF00017 | 0.358 | 
| LIG_SH2_SRC | 402 | 405 | PF00017 | 0.358 | 
| LIG_SH2_STAT3 | 283 | 286 | PF00017 | 0.324 | 
| LIG_SH2_STAT3 | 485 | 488 | PF00017 | 0.574 | 
| LIG_SH2_STAT5 | 220 | 223 | PF00017 | 0.489 | 
| LIG_SH2_STAT5 | 283 | 286 | PF00017 | 0.324 | 
| LIG_SH2_STAT5 | 390 | 393 | PF00017 | 0.340 | 
| LIG_SH2_STAT5 | 402 | 405 | PF00017 | 0.340 | 
| LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.352 | 
| LIG_SH3_3 | 17 | 23 | PF00018 | 0.412 | 
| LIG_SUMO_SIM_anti_2 | 310 | 317 | PF11976 | 0.324 | 
| LIG_SUMO_SIM_anti_2 | 408 | 413 | PF11976 | 0.340 | 
| LIG_SUMO_SIM_par_1 | 136 | 143 | PF11976 | 0.501 | 
| LIG_SUMO_SIM_par_1 | 38 | 44 | PF11976 | 0.536 | 
| LIG_SUMO_SIM_par_1 | 446 | 452 | PF11976 | 0.439 | 
| LIG_SUMO_SIM_par_1 | 54 | 60 | PF11976 | 0.302 | 
| LIG_UBA3_1 | 244 | 251 | PF00899 | 0.439 | 
| MOD_CDK_SPxxK_3 | 19 | 26 | PF00069 | 0.566 | 
| MOD_CK1_1 | 33 | 39 | PF00069 | 0.458 | 
| MOD_CK1_1 | 81 | 87 | PF00069 | 0.525 | 
| MOD_CK2_1 | 36 | 42 | PF00069 | 0.450 | 
| MOD_CK2_1 | 378 | 384 | PF00069 | 0.413 | 
| MOD_Cter_Amidation | 121 | 124 | PF01082 | 0.392 | 
| MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.596 | 
| MOD_GlcNHglycan | 174 | 177 | PF01048 | 0.735 | 
| MOD_GlcNHglycan | 286 | 289 | PF01048 | 0.327 | 
| MOD_GlcNHglycan | 427 | 430 | PF01048 | 0.460 | 
| MOD_GlcNHglycan | 479 | 482 | PF01048 | 0.542 | 
| MOD_GSK3_1 | 106 | 113 | PF00069 | 0.511 | 
| MOD_GSK3_1 | 188 | 195 | PF00069 | 0.669 | 
| MOD_GSK3_1 | 225 | 232 | PF00069 | 0.492 | 
| MOD_GSK3_1 | 319 | 326 | PF00069 | 0.413 | 
| MOD_GSK3_1 | 448 | 455 | PF00069 | 0.324 | 
| MOD_N-GLC_1 | 110 | 115 | PF02516 | 0.449 | 
| MOD_N-GLC_1 | 418 | 423 | PF02516 | 0.411 | 
| MOD_N-GLC_1 | 476 | 481 | PF02516 | 0.523 | 
| MOD_NEK2_1 | 110 | 115 | PF00069 | 0.390 | 
| MOD_NEK2_1 | 274 | 279 | PF00069 | 0.382 | 
| MOD_NEK2_2 | 319 | 324 | PF00069 | 0.380 | 
| MOD_NEK2_2 | 63 | 68 | PF00069 | 0.305 | 
| MOD_PIKK_1 | 185 | 191 | PF00454 | 0.659 | 
| MOD_PIKK_1 | 225 | 231 | PF00454 | 0.589 | 
| MOD_PKA_1 | 203 | 209 | PF00069 | 0.563 | 
| MOD_PKA_1 | 351 | 357 | PF00069 | 0.396 | 
| MOD_PKA_1 | 475 | 481 | PF00069 | 0.460 | 
| MOD_PKA_2 | 203 | 209 | PF00069 | 0.553 | 
| MOD_PKA_2 | 336 | 342 | PF00069 | 0.334 | 
| MOD_PKA_2 | 351 | 357 | PF00069 | 0.396 | 
| MOD_PKA_2 | 475 | 481 | PF00069 | 0.449 | 
| MOD_PKB_1 | 201 | 209 | PF00069 | 0.621 | 
| MOD_Plk_1 | 192 | 198 | PF00069 | 0.559 | 
| MOD_Plk_2-3 | 440 | 446 | PF00069 | 0.285 | 
| MOD_Plk_4 | 351 | 357 | PF00069 | 0.394 | 
| MOD_Plk_4 | 36 | 42 | PF00069 | 0.504 | 
| MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.379 | 
| MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.536 | 
| MOD_ProDKin_1 | 314 | 320 | PF00069 | 0.324 | 
| MOD_SUMO_for_1 | 266 | 269 | PF00179 | 0.434 | 
| MOD_SUMO_for_1 | 301 | 304 | PF00179 | 0.324 | 
| TRG_DiLeu_BaEn_4 | 396 | 402 | PF01217 | 0.340 | 
| TRG_ENDOCYTIC_2 | 340 | 343 | PF00928 | 0.324 | 
| TRG_ENDOCYTIC_2 | 355 | 358 | PF00928 | 0.379 | 
| TRG_ENDOCYTIC_2 | 371 | 374 | PF00928 | 0.369 | 
| TRG_ENDOCYTIC_2 | 402 | 405 | PF00928 | 0.329 | 
| TRG_ENDOCYTIC_2 | 486 | 489 | PF00928 | 0.454 | 
| TRG_ER_diArg_1 | 133 | 135 | PF00400 | 0.387 | 
| TRG_ER_diArg_1 | 201 | 204 | PF00400 | 0.573 | 
| TRG_ER_diArg_1 | 349 | 352 | PF00400 | 0.407 | 
| TRG_NES_CRM1_1 | 399 | 415 | PF08389 | 0.329 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N0P645 | Leptomonas seymouri | 80% | 100% | 
| A0A0S4JEQ3 | Bodo saltans | 63% | 100% | 
| A0A1X0NG29 | Trypanosomatidae | 23% | 92% | 
| A0A1X0NNW8 | Trypanosomatidae | 68% | 100% | 
| A0A3S7WSB4 | Leishmania donovani | 100% | 100% | 
| A0A422NNY9 | Trypanosoma rangeli | 66% | 100% | 
| A4H723 | Leishmania braziliensis | 88% | 100% | 
| D0A6V7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 64% | 100% | 
| E9AP50 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% | 
| Q4QGD8 | Leishmania major | 98% | 100% | 
| V5BIC8 | Trypanosoma cruzi | 67% | 100% |